The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Source: 
Yahoo/Benzinga
snippet: 

Biotech stocks came under pressure last week despite two FDA approvals coming through. The FDA approved SAGE Therapeutics Inc (NASDAQ: SAGE)'s drug to treat postpartum depression and Jazz Pharmaceuticals PLC (NASDAQ: JAZZ)'s sleep disorder drug.